Sat, Sep 20, 2014, 6:55 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • faosto faosto Jan 28, 2013 4:51 PM Flag

    What's the sentiment here on Kynamro?

    Will it be approved tomorrow (1), or rejected (2)? I figure if it is approved, AEGR will take a $2-3 hit, and if it is rejected, it will rise another $2-3.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • system_architect_enterprise system_architect_enterprise Jan 29, 2013 10:38 PM Flag

      AEGR may take a hit momentarily, but not from any smart money, only from retail investors day-trading to see if they can make it move. Anybody with any understanding of the market will know that Kynamro's approval will turn to a good thing for AEGR. Only those behind the power curve, and didn't know that lomitapide was approved back on December 24, would try to knock AEGR on this. AEGR was approved first, will be first to market, and will dominate marketshare right out of the gate.

      The REMS on Kynamro is rightfully restrictive, but the bigger issue is the difference between FDA approval and commercial success. I think a long time ago they had a treatment for AIDS, but the market never bought it, so the FDA approval became irrelevant. Such will be the case here.

 
AEGR
32.87-1.23(-3.61%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.